Results 171 to 180 of about 76,053 (241)

An integrative pharmacovigilance, network toxicology and molecular docking study on drug-induced cheilitis. [PDF]

Front Pharmacol
Wang X, Han S, Huang Y, Zhang L, Li X, Yang L, Zhang Y.   +6 more
europepmc   +1 more source

Real-world evidence on second line chemotherapy in advanced biliary tract carcinoma refractory to gemcitabine and oxaliplatin (GemOx). [PDF]

BMC Cancer
Lagenfelt H, Blomstrand H, Gränsmark E, Elander NO.   +3 more
europepmc   +1 more source

Real-World Efficacy of Nab-Paclitaxel Plus Capecitabine and a PD-1 Inhibitor in Metastatic or Locally Advanced Esophageal Cancer. [PDF]

Cancer Med
Wang Y, Zhang WJ, Lu YX, Liu SL, Zhang ZY, Zhang SM, Wang TW, Zhong Y, Zhang DS.   +8 more
europepmc   +1 more source

Impact of sex on chemotherapy toxicity and efficacy in biliary tract cancer: Analysis of ABC, BILCAP trials and population data. [PDF]

JHEP Rep
Wagner AD, Lopes A, Chambers P, Valle JW, Primrose J, Twelves C, Steventon L, Wang Z, Dodwell D, Bridgewater J.   +9 more
europepmc   +1 more source

Efficacy of Bidirectional Paclitaxel plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single Institution Analysis of Two Phase II Clinical Trials. [PDF]

Ann Surg Oncol
Gallanis AF, Perati SR, Canady SN, Epstein M, Moore N, Satterwhite AA, Mallory Y, Ahn D, Bowden C, Figueiroa S, Lee JJ, de Souza A, Shin S, Ahmed J, Sullivan MA, Joyce SR, Hernandez JM, Chen A, Alewine CC, Davis JL, Blakely AM.   +20 more
europepmc   +1 more source

In silico identification of bilobetin and ginsenoside as dual CK2 and ULK2 inhibitors targeting triple-negative breast cancer. [PDF]

Sci Rep
Hossain MA, Tamanna IJ, Hossain MS, Parvez A, Afrin S, Sobuj DR, Islam MT, Al Noman A, Ahmed M, Sultana S, Srivastava S, Rao GSNK, Khan SR, Babu MR, Tariq M, Saiyad MT, Hamzah Z, Jain M.   +17 more
europepmc   +1 more source

Low-Dose Metronomic Chemotherapy With Fixed Low-Dose Nivolumab for Recurrent Cervical Cancer After Radiotherapy: Experience From Routine Clinical Practice. [PDF]

Cureus
Ramidi GR, Yadav R, Sunny G, Patnaik A.
europepmc   +1 more source

CDK4/6 inhibitors for premenopausal women with hormone receptor-positive/HER2-negative breast cancer; insight from Young-PEARL. [PDF]

Transl Breast Cancer Res
Tokunaga E.
europepmc   +1 more source

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2⁺ breast cancer: TBCRC049 phase 2 study results. [PDF]

Nat Cancer
Murthy RK, O'Brien BJ, Berry DA, Singareeka-Raghavendra A, Monroe MG, Johnson J, White J, Schwartz-Gomez J, Topletz-Erickson A, Lobbous M, Riley K, Melisko M, Morikawa A, Ferguson SD, de Groot JF, Krop IE, Valero V, Rimawi MF, Wolff AC, Tripathy D, Lin NU, Stringer-Reasor EM.   +21 more
europepmc   +1 more source

活動量計とセルフレポートICTシステムを用いた抗 がん剤治療中の患者さんの身体的活動量の定量測定 [PDF]

, 2017
一瀬, 友希, 上田, 重人, 佐伯, 俊昭, 大崎, 昭彦, 島田, 浩子, 廣川, 詠子, 杉谷, 郁子, 藤堂, 真紀, 高橋, 孝郎   +8 more
core